Ophthalmic Drug Delivery in Glaucoma—A Review
AbstractGlaucoma is a progressive optic neuropathy and medical therapy is the initial option for the treatment of this potentially blinding condition. Topical instillation of eye drops from the bottle is the most common glaucoma drug delivery form. Due to limited permeability of anterior ocular surface, natural clearance and drainage, eye drops contain large amounts of inactive ingredients. Effective penetration enhancers are known as irritants causing ocular discomfort. Although drug efficacy is determined by active ingredients, inactive agents can affect tolerance and can result in conjunctival irritation and hyperemia and influence patients’ adherence and quality of life.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Januleviciene, I.; Siaudvytyte, L.; Barsauskaite, R. Ophthalmic Drug Delivery in Glaucoma—A Review. Pharmaceutics 2012, 4, 243-251.
Januleviciene I, Siaudvytyte L, Barsauskaite R. Ophthalmic Drug Delivery in Glaucoma—A Review. Pharmaceutics. 2012; 4(1):243-251.Chicago/Turabian Style
Januleviciene, Ingrida; Siaudvytyte, Lina; Barsauskaite, Ruta. 2012. "Ophthalmic Drug Delivery in Glaucoma—A Review." Pharmaceutics 4, no. 1: 243-251.